Share

June 2014; 1 (1) ArticleOpen Access

Predictors of recurrence following an initial episode of transverse myelitis

Dorlan J. Kimbrough, Maureen A. Mealy, Alexandra Simpson, Michael Levy
First published April 24, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000004
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2641

Share

Article Information

vol. 1 no. 1 e4
DOI: 
https://doi.org/10.1212/NXI.0000000000000004
PubMed: 
25340060
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received March 11, 2014
  • Accepted in final form March 17, 2014
  • First Published April 24, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Dorlan J. Kimbrough, MD,
    2. Maureen A. Mealy, RN,
    3. Alexandra Simpson, MS and
    4. Michael Levy, MD, PhD
  1. Dorlan J. Kimbrough, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consulting fees from Medical Logix, LLC for the development of continuing medical education programs.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Educational grant support from Teva Pharmaceuticals

    Research Support, Government Entities:

    1. National Institutes of Health T32 Training Program in Neuroinfectious Diseases and Neuroimmunology at Johns Hopkins University, 5T32NS069351-2, Fellow, 2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Maureen A. Mealy, RN,
    3. Scientific Advisory Boards:

    1. Served on an advisory board for Novartis Pharmaceuticals.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alexandra Simpson, MS and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Michael Levy, MD, PhD
    5. Scientific Advisory Boards:

    1. Asterias

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Asterias, Guthy Jackson Charitable Foundation to present data

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. The Neurology and Psychiatry Work-Up (Patient Encounters), Lippincott Williams & Wilkins; 1 edition (December 1, 2009)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. ApoPharma Inc., NeuralStem Inc., Viropharma (Shire), Sanofi, Genentech, Acorda

    Research Support, Government Entities:

    1. National Institute of Neurological Diseases and Stroke

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Guthy-Jackson Charitable Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Johns Hopkins University, Baltimore, MD.
  1. Correspondence to Dr. Levy: mlevy{at}jhmi.edu
View Full Text

Article usage

Article usage: April 2014 to August 2023

AbstractFullPdfSource
Apr 20145973353Highwire
May 2014141269129Highwire
Jun 2014883176165Highwire
Jul 20142854758Highwire
Aug 201419613635Highwire
Sep 20141044128Highwire
Oct 20142014435Highwire
Nov 20141327629Highwire
Dec 20148413423Highwire
Jan 20158410814Highwire
Jan 201504925pmc
Feb 201563766Highwire
Feb 201505328pmc
Mar 20158514815Highwire
Mar 201505829pmc
Apr 20158811132Highwire
Apr 201505033pmc
May 20154511929Highwire
May 201504121pmc
Jun 20156112527Highwire
Jun 201502920pmc
Jul 2015579124Highwire
Jul 201503921pmc
Aug 2015829813Highwire
Aug 201503115pmc
Sep 2015817912Highwire
Sep 201503110pmc
Oct 20152110412Highwire
Oct 201502517pmc
Nov 20154210910Highwire
Nov 201503119pmc
Dec 2015251268Highwire
Dec 201503518pmc
Jan 2016391276Highwire
Jan 201604015pmc
Feb 20162313422Highwire
Feb 201601712pmc
Mar 20163217515Highwire
Mar 201602220pmc
Apr 20162716410Highwire
Apr 201602013pmc
May 20164316517Highwire
May 201601712pmc
Jun 20163612510Highwire
Jun 20160185pmc
Jul 201615812114Highwire
Jul 20160133pmc
Aug 20163912311Highwire
Aug 20160189pmc
Sep 2016261066Highwire
Sep 20160156pmc
Oct 2016201417Highwire
Oct 20160145pmc
Nov 201613952Highwire
Nov 2016075pmc
Dec 2016101246Highwire
Dec 201601614pmc
Jan 2017161766Highwire
Jan 20170176pmc
Feb 2017101711Highwire
Feb 20170137pmc
Mar 20172223611Highwire
Mar 20170135pmc
Apr 2017161804Highwire
Apr 2017122223pmc
May 2017181634Highwire
May 201751111pmc
Jun 201762005Highwire
Jun 2017101822pmc
Jul 201763465Highwire
Jul 201731314pmc
Aug 2017273906Highwire
Aug 201783139pmc
Sep 2017123064Highwire
Sep 201742226pmc
Oct 2017113358Highwire
Oct 201731112pmc
Nov 2017173326Highwire
Nov 201772623pmc
Dec 20174774Highwire
Jan 20184918Highwire
Feb 20184875Highwire
Mar 2018933311Highwire
Apr 201833145Highwire
Apr 201811516pmc
May 201852608Highwire
Jun 201822226Highwire
Jun 201811920pmc
Jul 2018317810Highwire
Aug 201831466Highwire
Aug 201832530pmc
Sep 201801415Highwire
Oct 2018216612Highwire
Nov 2018820610Highwire
Dec 2018733314Highwire
Jan 20191022518Highwire
Feb 20191720113Highwire
Mar 2019833111Highwire
Apr 2019212112Highwire
May 20191011527Highwire
Jun 2019515116Highwire
Jul 2019712520Highwire
Aug 2019752025Highwire
Sep 2019711217Highwire
Oct 2019712219Highwire
Nov 2019611817Highwire
Dec 20191015019Highwire
Jan 202062007Highwire
Feb 2020216614Highwire
Mar 2020114113Highwire
Apr 202001459Highwire
May 202011148Highwire
Jun 2020110314Highwire
Jul 2020112110Highwire
Aug 2020013811Highwire
Sep 2020521018Highwire
Oct 2020526515Highwire
Nov 202061379Highwire
Dec 2020114610Highwire
Jan 2021520026Highwire
Feb 2021514616Highwire
Mar 20211334014Highwire
Apr 2021431926Highwire
May 2021630117Highwire
Jun 2021331327Highwire
Jul 20211734130Highwire
Aug 2021732525Highwire
Sep 2021624525Highwire
Oct 20211621728Highwire
Nov 2021414030Highwire
Dec 2021613114Highwire
Jan 2022214815Highwire
Feb 2022514911Highwire
Mar 2022521316Highwire
Apr 2022614716Highwire
May 2022617715Highwire
Jun 2022410112Highwire
Jul 20221216915Highwire
Aug 20221318811Highwire
Sep 2022813123Highwire
Oct 2022515213Highwire
Nov 20221120827Highwire
Dec 2022612110Highwire
Jan 2023417221Highwire
Feb 2023317116Highwire
Mar 2023513317Highwire
Apr 202338523Highwire
May 2023514018Highwire
Jun 2023211918Highwire
Jul 202348729Highwire
Aug 20235849Highwire

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me

Recommended articles